Navigation Links
Clinical Trial Excellence: Shaping Markets Through Early,Communication of Clinical Trial Data

CHAPEL HILL, N.C., May 25, 2007 /PRNewswire/ -- With enormous investments and the success of a pharmaceutical product at play, pharmaceutical firms need to develop effective strategies for communicating clinical trial results early. Companies that master their communication planning and execution will gain a significant advantage in the marketplace.

According to research and consulting firm Best Practices, LLC, successful companies create communication plans long before the interim or final results for a landmark trial are available. For example, one surveyed company establishes its integrated communication strategy as early as Phase I. In addition, leading companies also develop early scenario planning for good, bad, neutral and most likely study results.

"From Breakthrough to Blockbuster: Best Practices in Communicating Clinical Trial Results" - available with a complimentary study excerpt at http://www3.best-in-class.com/rr805.htm - examines the most effective practices for communicating clinical trial results to physicians, the managed care community, investors and consumers.

The extensive report includes over 100 best practices, metrics and narratives; a clinical communication toolkit that can help executives with the development of a communication plan or activity checklist to prepare for post- launch communication tactics. Study findings include:

    -- Communicating to Physicians: 60% of benchmarked pharmaceutical

       companies begin communicating to physicians more than six months prior

       to the drug launch. However, executives also warn that too early

       communication might trigger the opposite.

    -- Communicating to Managed Care Organizations: The information

       requirements are significantly different from the needs of physicians,

       because in addition to drug indication
s MCOs are also looking for

       complex pricing information. One benchmarked company involves pharmacy

       directors in ancillary studies that look at utilization data,

       activities necessary for government or private payers and cost-benefit-

       ratios for the drug.

    -- Communicating to Consumers: One executive identified tailoring messages

       to community and patient advocacy groups by therapeutic area as the

       most innovative public relations activity. For example, the company

       hosts separate events for consumer and advocacy leaders in the

       community.

Download the report excerpt online at http://www3.best-in-class.com/rr805.htm to view sample best practices and performance metrics.

To drill down on the numerous metrics presented in this report more deeply contact our Solution Specialists at (919) 403-0251 or . bestpractices@best-in-class.com

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.

CONTACT: Kimberly Hardin of Best Practices, LLC, +1-919-767-9221, or khardin@best-in-class.com

Web site: http://www3.best-in-class.com/rr805.htm/http://www.best-in-class.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... -- FDA 510(k) clearance covers Confocal ... urological and surgical applications Mauna Kea ... the multidisciplinary confocal laser endomicroscopy (CLE) platform, today ... with the 12 th 510(k) clearance from ... new FDA clearance covers Confocal Miniprobes indicated for ...
(Date:5/25/2016)... Germany and GERMANTOWN, Maryland , ... QGEN ; Frankfurt Prime Standard: QIA) today announced ... agreement with Therawis Diagnostics GmbH to develop and commercialize predictive ... and market PITX2 as a marker to predict effectiveness of ... patients. "We are pleased to partner with Therawis, ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... ... strategic sales leadership and to further develop their rapidly expanding portfolio of customer ... Administration with a concentration in Marketing and an M.B.A. with concentration in management ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... surgical safety efforts for several years, and the efforts have paid off. ... efforts include new standards of care to enhance perioperative patient experiences and reduce ...
(Date:5/26/2016)... Vegas, NV (PRWEB) , ... May 26, 2016 , ... ... Ergonomic Tools,” identifies the impact of mobile devices on the billions of users, hundreds ... backs and necks. While not life threatening, the frequent and common action of ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... seeking nominations to serve on its Accreditation and Standards Committees and support ... quality-benchmarking activities incorporate key process and outcome measures, with the ultimate mission ...
(Date:5/26/2016)... ... May 26, 2016 , ... In 1980, Bill Howe opened ... throughout the beach community. His vision to grow the company was built on a ... maintain the highest level of training and customer service. Over 35 years later, Bill ...
Breaking Medicine News(10 mins):